Cite
HARVARD Citation
Tripathy, D. et al. (2018). Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial. Lancet oncology. 19 (7), pp. 904-915. [Online].